Perbedaan Diagnos Laboratorium Utama Tbk. dan UBC Medical Indonesia Tbk.: Diagnos Laboratorium Utama Tbk. diperdagangkan di Rp224 (kapitalisasi pasar 310,75 M, volume 24 jam 963,6 rb), sedangkan UBC Medical Indonesia Tbk. diperdagangkan di Rp146 (kapitalisasi pasar 584,6 M, volume 24 jam 817,3 rb). Perbedaan utamanya: UBC Medical Indonesia Tbk. lebih besar dari sisi kapitalisasi pasar, dan Diagnos Laboratorium Utama Tbk. lebih aktif diperdagangkan (963,6 rb vs 817,3 rb). Mana yang lebih baik tergantung tujuan investasimu.
| DGNS | LABS | |
|---|---|---|
Kapitalisasi Pasar | 310,75 M | 584,6 M |
Volume | 963,6 rb | 817,3 rb |
Lot | 9,64 rb | 8,17 rb |
Perputaran | 217,67 jt | 120,01 jt |
Harga Rata-rata | 225,89 | 146,84 |
Nilai Transaksi | 217,67 jt | 120,01 jt |
Harga Ekuilibrium Indikatif | 226 | 146 |
Volume Ekuilibrium Indikatif | 1 rb | 59 |
Imbal hasil berjalan pada periode standar
Berita terbaru kedua aset
PT Diagnos Laboratorium Utama Tbk (the “Company”) was established in the Republic of Indonesia on August 29, 2007 under framework of the Domestic Capital Investment Law No. 6 Year 1968 based on Deed No.17 dated August 29, 2007, of Martinef, S.H., M.Si., Notary in Bekasi. The Company started its commercial operation in 2008.
Selengkapnya di halaman DGNS →PT UBC Medical Indonesia (the Company) was established under the framework of Law of the Republic of Indonesia No. 20 year 1994 concerning the Foreign Capital Investment, as amended by Law No. 25 year 2007 concerning the Capital Investment based on Notarial Deed No. 01 dated 4 June 2014 of Novita Puspitarini, S.H., Notary in Jakarta. The Company started its commercial activities in October 2014. The parent entity as well as the ultimate parent entity of the Company is PT Optel Investama Mulia.
Selengkapnya di halaman LABS →